Whether you’re 5 or 15, back-to-school season can involve all sorts of overwhelming factors when living with pulmonary hypertension (PH) or another complex illness. Along with shopping for school supplies and planning an outfit for school pictures, PH warriors also have to worry about medication management, energy allowance, and…
Read more
Stanford University has been awarded a grant from the U.S. National Institutes of Health (NIH) to begin a Phase 2 clinical trial of pulmonary arterial hypertension (PAH) treatment tiprelestat, the treatment’s developer announced. Tiakis Biotech said tiprelestat was found to be safe in earlier clinical trials involving more…
Corvista Health’s point-of-care device can detect cases of pulmonary hypertension (PH) that other noninvasive diagnostic tools miss, according to a recent case series. “By enabling physicians to identify pulmonary hypertension within minutes, non-invasively, and even when traditional tests fail, we are offering a new standard of care that…
Get regular updates to your inbox.
